Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,913,188
  • Shares Outstanding, K 28,168
  • Annual Sales, $ 2,109 M
  • Annual Income, $ 404,390 K
  • EBIT $ 536 M
  • EBITDA $ 565 M
  • 60-Month Beta 1.42
  • Price/Sales 7.87
  • Price/Cash Flow 42.45
  • Price/Book 56.81

Options Overview Details

View History
  • Implied Volatility 38.66% ( -1.75%)
  • Historical Volatility 39.66%
  • IV Percentile 50%
  • IV Rank 27.08%
  • IV High 70.52% on 04/11/25
  • IV Low 26.83% on 08/15/25
  • Put/Call Vol Ratio 1.17
  • Today's Volume 52
  • Volume Avg (30-Day) 206
  • Put/Call OI Ratio 1.71
  • Today's Open Interest 4,892
  • Open Int (30-Day) 4,192

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 4.18
  • Number of Estimates 4
  • High Estimate 4.35
  • Low Estimate 4.09
  • Prior Year 3.67
  • Growth Rate Est. (year over year) +13.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
497.33 +20.73%
on 10/13/25
625.00 -3.93%
on 10/23/25
+99.22 (+19.80%)
since 10/10/25
3-Month
436.78 +37.47%
on 08/11/25
625.00 -3.93%
on 10/23/25
+166.09 (+38.24%)
since 08/08/25
52-Week
250.05 +140.13%
on 04/22/25
625.00 -3.93%
on 10/23/25
+237.65 (+65.51%)
since 11/08/24

Most Recent Stories

More News
1 Mid-Cap Stock to Target This Week and 2 We Ignore

1 Mid-Cap Stock to Target This Week and 2 We Ignore

MEDP : 600.44 (+1.92%)
DG : 100.40 (+1.19%)
SGI : 93.50 (+2.47%)
3 Cash-Heavy Stocks Worth Your Attention

3 Cash-Heavy Stocks Worth Your Attention

MEDP : 600.44 (+1.92%)
CPNG : 28.92 (+0.14%)
LOPE : 163.25 (-1.72%)
5 Revealing Analyst Questions From Medpace’s Q3 Earnings Call

5 Revealing Analyst Questions From Medpace’s Q3 Earnings Call

MEDP : 600.44 (+1.92%)
MEDP Q3 Deep Dive: Broad-Based Growth and Strong Pipeline Fuel Upbeat Outlook

MEDP Q3 Deep Dive: Broad-Based Growth and Strong Pipeline Fuel Upbeat Outlook

MEDP : 600.44 (+1.92%)
Stocks Muted Before the Open With Earnings in Focus

December S&P 500 E-Mini futures (ESZ25) are up +0.01%, and December Nasdaq 100 E-Mini futures (NQZ25) are down -0.08% this morning as investors digest quarterly results from major companies, including...

MEDP : 600.44 (+1.92%)
NFLX : 1,120.07 (+1.49%)
F : 13.16 (-0.38%)
MOH : 140.90 (-7.34%)
KER.P.DX : 313.325 (+0.89%)
DSY.FP : 23.820 (+0.97%)
NQZ25 : 25,574.75 (-0.54%)
TXN : 160.58 (+0.02%)
IONQ : 55.37 (-6.58%)
RGTI : 33.08 (-2.04%)
LII : 489.42 (-0.57%)
TMUS : 205.87 (-0.55%)
Medpace (NASDAQ:MEDP) Beats Q3 Sales Expectations, Stock Jumps 18.5%

Medpace (NASDAQ:MEDP) Beats Q3 Sales Expectations, Stock Jumps 18.5%

MEDP : 600.44 (+1.92%)
Medpace: Q3 Earnings Snapshot

Medpace: Q3 Earnings Snapshot

MEDP : 600.44 (+1.92%)
Medpace Holdings, Inc. Reports Third Quarter 2025 Results

Revenue of $659.9 million in the third quarter of 2025 increased 23.7% from revenue of $533.3 million for the comparable prior-year period, representing a backlog conversion rate of 23.0%. ...

MEDP : 600.44 (+1.92%)
Medpace (MEDP) Reports Earnings Tomorrow: What To Expect

Medpace (MEDP) Reports Earnings Tomorrow: What To Expect

MEDP : 600.44 (+1.92%)
1 High-Flying Stock to Research Further and 2 That Underwhelm

1 High-Flying Stock to Research Further and 2 That Underwhelm

MEDP : 600.44 (+1.92%)
KAI : 265.96 (-1.15%)
SNBR : 4.36 (-5.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

3rd Resistance Point 622.54
2nd Resistance Point 613.13
1st Resistance Point 606.79
Last Price 600.44
1st Support Level 591.03
2nd Support Level 581.63
3rd Support Level 575.28

See More

52-Week High 625.00
Last Price 600.44
Fibonacci 61.8% 481.77
Fibonacci 50% 437.52
Fibonacci 38.2% 393.28
52-Week Low 250.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar